Company Search:
Advanced Search
Sponsored Links
Auscann Group Holdings Ltd Company Snapshot
Auscann Group Holdings Ltd operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Auscann Group Holdings Ltd with three other pharmaceutical manufacturers in Australasia: Prescient Therapeutics Ltd (2018 sales of 125,156.00 Australian Dollars [US$89,270.02 ] ), Genetic Technologies Limited (189,254.00 Australian Dollars [US$134,989.20 ] of which 100% was Operations), and Prana Biotechnology Limited (201,174.00 Australian Dollars [US$143,491.38 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Auscann Group Holdings Ltd
  Stock Performance Chart for Auscann Group Holdings Ltd
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): .44
(Figures in Australian Dollars)
1 Week 0.0%   13 Weeks -41.7%  
4 Weeks -44.7%   52 Weeks -71.6%  
Auscann Group Holdings Ltd Key Data:
  Ticker: AC8 Country: Australia
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2018 Sales 235,064
(Year Ending Jan 2019).
Employees: 27
  Currency: Australian Dollars Market Cap: 121,824,020
  Fiscal Yr Ends: June Shares Outstanding: 276,872,772
  Share Type: Ordinary Closely Held Shares: 123,440,487
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.